Market for prescription drugs for acne Acne is a common disease that leads to the formation of lesions or pimples. The disease is chara...
Market for prescription drugs for acne
Acne is a common disease that leads to the formation of lesions or pimples. The disease is characterized by an overproduction of sebum due to the high production of the male hormone androgen in puberty. The hyperactivity of the hormone causes excessive sebum production. Sebum is an oily substance that forms in the sebaceous gland just below the skin surface. Sebum is widely recognized as a natural moisturizer for the skin. Excessive sebum secretion, however, leads to the appearance of pimples. Acne is characterized by the formation of nodules (large papules), comedones (blackheads and pimples), seborrhoea (scaly red skin), scars and pimples.
Overview of the report @
https://www.transparencymarketresearch.com/prescription-antiacne-drugs-market.html
Acne is reported to be a common problem in adolescents: approximately 90% to 95% of adolescent boys and 83% and 85% of adolescents 16 to 17 years of age have pimples. This disease tends to dissipate in middle age. However, 20% of adolescents in adulthood may have persistent acne. According to various sources from 2010, around 650 million people were affected by acne, and acne was also classified as the eighth most common disease in the world.
Acne is known to be caused by many factors, including hormonal factors, genetic factors, psychological factors, diet and infectious agents. Acne can not be permanently cured, but there are acne medications available on the market that can prevent scarring. Among the medicines available for treating acne are retinoids, antiandrogens, hormonal treatments, benzoyl peroxide, antisecretorrhea, keratolytic soaps, alpha hydroxy acids, salicylic acid, and others.
Request a brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12266
Prescription drug market: Segmentation
The market for prescription medicines for acne can be broadly classified according to various medicines available on the market. Accutane (isotretinoin), Desquam-E (benzoyl peroxide), Cleocin T (clindamycin phosphate), benzamycin, topical erythromycin (A / T / S, erythetia, t-stat), Retin-A (tretinoin) and Minocin (hydrochloride) minocycline) are several acne medications in the market.
In addition to the above medicines, tretinoin (Retin-A) is another popular acne treatment available in the form of gel and topical creams. In addition, all of the above medicines are not prescription and can be used without consultation with a doctor without a prescription. However, isotretinoin (Accutane), available in capsule form, is only available on prescription. In addition, combined antineoplastic agents such as BenzaClin, which combine clindamycin with benzoyl peroxide for effective acne treatment, are now available.
Adjustment Request @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12266
Market for Prescription Drugs for Acne: Geographic Dynamics
The market for prescription acne medications can also be broken down by region in North America, Europe, the Asia-Pacific region and the rest of the world. North America currently has the largest share of the world market for prescription acne medications. The predominance of this region is due to the presence of a large number of pharmaceutical manufacturers, which allow for easy market penetration, high awareness of the population and a higher prevalence of cancer. Acne. Ranbaxy Labs recently launched Absorica Capsules (isotretinoin) in the US market.
This product is also a flagship brand in the product portfolio of Ranbaxy Dermatology. Significant growth is expected in the Asia Pacific region due to changes in diet, lifestyle and increased patient awareness. In addition, the increasing prevalence of pharmaceutical agents in Asia would also increase Asia's market share in the acne medicines market. However, the side effects associated with the consumption of acne medications are an important factor that could hamper the growth of this market.
Ranbaxy Laboratories, Roche Diagnostics, Johnson & Johnson and others are among the leading players in this market.
